Aurinia Pharmaceuticals Inc (AUPH)
5.12
+0.07
(+1.39%)
USD |
NASDAQ |
Apr 23, 10:10
Aurinia Pharmaceuticals Price: 5.12 for April 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 22, 2024 | 4.98 | 5.06 | 4.92 | 5.05 | 1.167M |
Apr 19, 2024 | 4.79 | 5.01 | 4.77 | 4.99 | 1.574M |
Apr 18, 2024 | 4.91 | 4.955 | 4.71 | 4.81 | 2.098M |
Apr 17, 2024 | 5.04 | 5.09 | 4.91 | 4.91 | 1.145M |
Apr 16, 2024 | 5.01 | 5.08 | 4.96 | 5.00 | 855913.0 |
Apr 15, 2024 | 5.09 | 5.226 | 5.02 | 5.04 | 1.340M |
Apr 12, 2024 | 5.02 | 5.11 | 4.97 | 5.10 | 1.722M |
Apr 11, 2024 | 5.02 | 5.11 | 4.97 | 5.08 | 855153.0 |
Apr 10, 2024 | 4.99 | 5.06 | 4.95 | 4.99 | 1.652M |
Apr 09, 2024 | 4.99 | 5.26 | 4.98 | 5.11 | 1.501M |
Apr 08, 2024 | 5.05 | 5.05 | 4.97 | 4.98 | 831181.0 |
Apr 05, 2024 | 5.07 | 5.16 | 5.01 | 5.05 | 1.053M |
Apr 04, 2024 | 5.24 | 5.30 | 5.065 | 5.09 | 1.204M |
Apr 03, 2024 | 5.04 | 5.20 | 5.00 | 5.18 | 1.185M |
Apr 02, 2024 | 5.35 | 5.35 | 5.04 | 5.08 | 1.164M |
Apr 01, 2024 | 5.00 | 5.41 | 4.97 | 5.40 | 2.477M |
Mar 28, 2024 | 4.99 | 5.04 | 4.97 | 5.01 | 1.375M |
Mar 27, 2024 | 4.95 | 5.015 | 4.85 | 5.00 | 1.439M |
Mar 26, 2024 | 4.98 | 5.07 | 4.93 | 4.93 | 948678.0 |
Mar 25, 2024 | 5.00 | 5.07 | 4.96 | 4.99 | 969097.0 |
Mar 22, 2024 | 5.03 | 5.03 | 4.94 | 4.97 | 1.792M |
Mar 21, 2024 | 5.20 | 5.25 | 5.00 | 5.01 | 1.871M |
Mar 20, 2024 | 5.15 | 5.23 | 5.025 | 5.14 | 1.808M |
Mar 19, 2024 | 5.05 | 5.19 | 4.96 | 5.18 | 1.177M |
Mar 18, 2024 | 5.18 | 5.22 | 5.06 | 5.09 | 1.267M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.88
Minimum
Oct 14 2019
33.08
Maximum
Oct 29 2021
11.79
Average
11.21
Median
May 18 2022
Price Benchmarks
Lexaria Bioscience Corp | 2.21 |
Acasti Pharma Inc | 2.76 |
Edesa Biotech Inc | 4.43 |
Xenon Pharmaceuticals Inc | 40.98 |
ESSA Pharma Inc | 7.01 |
Price Related Metrics
PS Ratio | 4.171 |
Price to Book Value | 1.959 |
Earnings Yield | -10.35% |
Market Cap | 740.44M |